OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer
In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development EngineNANTES, France, Dec. 21, 2021 (GLOBE NEWSWIRE) — OSE…